Connection

David Priest to Tumor Cells, Cultured

This is a "connection" page, showing publications David Priest has written about Tumor Cells, Cultured.
Connection Strength

0.260
  1. The enhancement of the activity of 10-propargyl-5,8-dideazafolate and 5,10-dideazatetrahydrofolate by inhibitors of dihydrofolate reductase. Adv Enzyme Regul. 1989; 28:13-21.
    View in: PubMed
    Score: 0.069
  2. Effects of antisense-based folypoly-gamma-glutamate synthetase down-regulation on reduced folates and cellular proliferation in CCRF-CEM cells. Biochem Pharmacol. 1998 Jun 15; 55(12):2031-7.
    View in: PubMed
    Score: 0.033
  3. Disposition of leucovorin and its metabolites in the plasma, intestinal epithelium, and intraperitoneal L1210 cells of methotrexate-pretreated mice. Cancer Chemother Pharmacol. 1994; 34(6):455-8.
    View in: PubMed
    Score: 0.024
  4. Folate metabolites as modulators of antitumor drug activity. Adv Exp Med Biol. 1993; 338:693-8.
    View in: PubMed
    Score: 0.023
  5. Role of methylenetetrahydrofolate depletion in methotrexate-mediated intracellular thymidylate synthesis inhibition in cultured L1210 cells. Cancer Res. 1988 Jun 15; 48(12):3398-404.
    View in: PubMed
    Score: 0.017
  6. The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis. Biochem Pharmacol. 2003 Mar 01; 65(5):765-71.
    View in: PubMed
    Score: 0.012
  7. Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines. Biochem J. 2002 Nov 01; 367(Pt 3):741-50.
    View in: PubMed
    Score: 0.011
  8. Re: Folylpolyglutamyl synthetase gene transfer and glioma antifolate sensitivity in culture and in vivo. J Natl Cancer Inst. 1999 Dec 01; 91(23):2047-50.
    View in: PubMed
    Score: 0.009
  9. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. J Biol Chem. 1998 Nov 13; 273(46):30189-98.
    View in: PubMed
    Score: 0.009
  10. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells. Adv Enzyme Regul. 1997; 37:59-76.
    View in: PubMed
    Score: 0.008
  11. Growth of ovarian-carcinoma cell lines at physiological folate concentration: effect on folate-binding protein expression in vitro and in vivo. Int J Cancer. 1995 Nov 03; 63(3):395-401.
    View in: PubMed
    Score: 0.007
  12. Rapid quantitative PCR for determination of relative gene expressions in tissue specimens. PCR Methods Appl. 1995 Apr; 4(5):305-8.
    View in: PubMed
    Score: 0.007
  13. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM. Cancer Res. 1995 Feb 01; 55(3):566-73.
    View in: PubMed
    Score: 0.007
  14. Altered transport of folic acid and antifolates through the carrier mediated reduced folate transport system in a human leukemia cell line resistant to (6R) 5,10-dideazatetrahydrofolic acid (DDATHF). Adv Exp Med Biol. 1993; 338:775-8.
    View in: PubMed
    Score: 0.006
  15. Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin. Cancer Res. 1991 Feb 01; 51(3):789-93.
    View in: PubMed
    Score: 0.005
  16. The effect of methotrexate on the folate coenzyme pools in human hepatoma cells in culture. Adv Exp Med Biol. 1991; 309A:75-8.
    View in: PubMed
    Score: 0.005
  17. Inhibition of mammalian thymidylate synthase by 10-formyltetrahydropteroylpolyglutamate. Arch Biochem Biophys. 1991 Jan; 284(1):219-22.
    View in: PubMed
    Score: 0.005
  18. Role of substrate depletion in the inhibition of thymidylate biosynthesis by the dihydrofolate reductase inhibitor trimetrexate in cultured hepatoma cells. Cancer Res. 1990 Jul 01; 50(13):3979-84.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.